Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 2
1979 5
1980 9
1981 7
1982 12
1983 5
1984 12
1985 17
1986 16
1987 21
1988 14
1989 22
1990 28
1991 19
1992 19
1993 11
1994 11
1995 11
1996 13
1997 11
1998 22
1999 16
2000 20
2001 19
2002 23
2003 24
2004 20
2005 16
2006 27
2007 31
2008 23
2009 27
2010 26
2011 28
2012 21
2013 16
2014 25
2015 24
2016 25
2017 32
2018 32
2019 30
2020 35
2021 25
Text availability
Article attribute
Article type
Publication date

Search Results

790 results
Results by year
Filters applied: . Clear all
Page 1
An update on vinpocetine: New discoveries and clinical implications.
Zhang YS, Li JD, Yan C. Zhang YS, et al. Eur J Pharmacol. 2018 Jan 15;819:30-34. doi: 10.1016/j.ejphar.2017.11.041. Epub 2017 Nov 26. Eur J Pharmacol. 2018. PMID: 29183836 Free PMC article. Review.
Currently, vinpocetine is also available in the market as a dietary supplement to enhance cognition and memory. ...These novel findings may facilitate the repositioning of vinpocetine for preventing or treating relevant disorders in humans....
Currently, vinpocetine is also available in the market as a dietary supplement to enhance cognition and memory. ...These novel findin …
Vinpocetine protects against the development of experimental abdominal aortic aneurysms.
Zhang C, Hsu CG, Mohan A, Shi H, Li D, Yan C. Zhang C, et al. Clin Sci (Lond). 2020 Nov 27;134(22):2959-2976. doi: 10.1042/CS20201057. Clin Sci (Lond). 2020. PMID: 33111936
We showed that vinpocetine pre-treatment remarkably attenuated aneurysmal dilation assessed by diameter and volume. ...Taken together, our findings reveal a novel role of vinpocetine in AAA formation, development and progression. Given the excellent safety profile o …
We showed that vinpocetine pre-treatment remarkably attenuated aneurysmal dilation assessed by diameter and volume. ...Taken together …
Vinpocetine in the treatment of poststroke cognitive dysfunction: A protocol for systematic review and meta-analysis.
Liu Y, Yin Y, Lu QL, Dan Y, Xu MS, Song G, Li C. Liu Y, et al. Medicine (Baltimore). 2019 Feb;98(6):e13685. doi: 10.1097/MD.0000000000013685. Medicine (Baltimore). 2019. PMID: 30732122 Free PMC article. Review.
BACKGROUND: Previous clinical trials have reported that vinpocetine can be used for the treatment of cognitive dysfunction. ...All randomized controlled trials (RCTs) of vinpocetine for PSCD will be considered for inclusion without the language restrictions. ...
BACKGROUND: Previous clinical trials have reported that vinpocetine can be used for the treatment of cognitive dysfunction. ...All ra …
Vinpocetine. Monograph.
[No authors listed] [No authors listed] Altern Med Rev. 2002 Jun;7(3):240-3. Altern Med Rev. 2002. PMID: 12126465 Free article. Review. No abstract available.
Synthesis and biological evaluation of Vinpocetine derivatives.
Pan BW, Shi Y, Li WC, Wang Q, Pan M, Wu Q, Fu HZ. Pan BW, et al. Bioorg Med Chem Lett. 2020 Jan 15;30(2):126472. doi: 10.1016/j.bmcl.2019.05.052. Epub 2019 May 28. Bioorg Med Chem Lett. 2020. PMID: 31859156
A new series of Vinpocetine derivatives were synthesized and evaluated for their inhibitory activity on PDE1A in vitro. ...After further screening, compounds 5, 7, 21, 34 and Vinpocetine were selected to examine the vasorelaxant effects on endothelium-intact rat tho …
A new series of Vinpocetine derivatives were synthesized and evaluated for their inhibitory activity on PDE1A in vitro. ...After furt …
ALSUntangled 57: Vinpocetine.
ALSUNTANGLED GROUP. ALSUNTANGLED GROUP. Amyotroph Lateral Scler Frontotemporal Degener. 2021 May;22(3-4):316-319. doi: 10.1080/21678421.2020.1786942. Epub 2020 Jul 1. Amyotroph Lateral Scler Frontotemporal Degener. 2021. PMID: 32608268 No abstract available.
Vinpocetine mitigates aluminum-induced cognitive impairment in socially isolated rats.
Ali AA, Ahmed HI, Khaleel SA, Abu-Elfotuh K. Ali AA, et al. Physiol Behav. 2019 Sep 1;208:112571. doi: 10.1016/j.physbeh.2019.112571. Epub 2019 Jun 6. Physiol Behav. 2019. PMID: 31175888
Several reports have highlighted the role of vinpocetine in Alzheimer's disease (AD). However, the role of vinpocetine in AD under social isolation conditions has not yet been elucidated. ...Hence, this study provides profound insights into the role of vin
Several reports have highlighted the role of vinpocetine in Alzheimer's disease (AD). However, the role of vinpocetine
Anti-inflammatory effects of vinpocetine in LPS-stimulated microglia via activation of AMPK.
Zhou Q, Guo D, Li X, Wang Y, Ye X, Xue S, Wang X. Zhou Q, et al. An Acad Bras Cienc. 2020 Nov 20;92(4):e20200241. doi: 10.1590/0001-3765202020200241. eCollection 2020. An Acad Bras Cienc. 2020. PMID: 33237143 Free article.
The present study investigated the anti-neuroinflammatory effects of vinpocetine induced by lipopolysaccharide (LPS) in BV2 microglia. BV2 microglia were pretreated with vinpocetine, and then stimulated with LPS (100 ng/mL). ...AMPK inhibition by siRNA blocked the a …
The present study investigated the anti-neuroinflammatory effects of vinpocetine induced by lipopolysaccharide (LPS) in BV2 microglia …
Vinpocetine regulates levels of circulating TLRs in Parkinson's disease patients.
Ping Z, Xiaomu W, Xufang X, Liang S. Ping Z, et al. Neurol Sci. 2019 Jan;40(1):113-120. doi: 10.1007/s10072-018-3592-y. Epub 2018 Oct 12. Neurol Sci. 2019. PMID: 30315378
Notably, Toll-like receptors (TLRs) may activate inflammatory or anti-inflammatory responses in Parkinson's disease. Vinpocetine has been tested as an anti-inflammatory in both animal and in vitro research. Thus, it is important to test whether the anti-inflammatory …
Notably, Toll-like receptors (TLRs) may activate inflammatory or anti-inflammatory responses in Parkinson's disease. Vinpocetine
Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss.
Zhu M, Liu H, Sun K, Liu J, Mou Y, Qi D, Zhou C, Abudunaibi M, Tasiken B, Li J, Cheng H, Huang H. Zhu M, et al. Biomed Pharmacother. 2020 Mar;123:109769. doi: 10.1016/j.biopha.2019.109769. Epub 2019 Dec 15. Biomed Pharmacother. 2020. PMID: 31846839 Free article.
The current pharmacological treatment for osteoporosis has many shortcomings, and more effective treatments are needed. Vinpocetine (Vinp), a derivative of the alkaloid vincamine, has been used to treat cerebrovascular disorders and cognitive impairment for a long time. .. …
The current pharmacological treatment for osteoporosis has many shortcomings, and more effective treatments are needed. Vinpocetine ( …
790 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page